Share on LinkedInShare on LinkedIn

ARTICLE · 19 NOVEMBER 2003

Swiss Competition Report - Reporting Period : July 03 – September 03

SwitzerlandAntitrust/Competition Law

This section reviews developments concerning the Federal Act of October 6, 1995 on Cartels and Other Restraints of Competition (the "Competition Act"), which is enforced by the Federal Competition Commission ("FCC"). Appeals against decisions of the FCC are heard by the Appeal Commission for Competition Matters (the "Appeal Commission").

ENFORCEMENT POLICY AND LEGISLATIVE DEVELOPMENTS

Therapeutic Products Act and Competition Act.

The FCC issued on September 23, 2003, an opinion addressed to the price Supervisor (Surveillant des prix) in favour of the applicability of the Competition Act to the sale of therapeutic products to public hospitals. A preliminary investigation showed that, after the entry into force of the Therapeutic Products Act ("TPA"), pharmaceutical companies changed their prices and discounts practices towards public hospitals, either altogether excluding discounts or uniformly reducing them to a maximum of 20 %. According to the FCC, the TPA aims at preventing

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from